Medtronic Fidelis Lead Failure Rate Climbs, But New Software May Help

Medtronic hopes new software for monitoring the integrity of implantable cardioverter defibrillator leads will allay physicians' and patients' fears about the high failure rate of the firm's Fidelis leads

More from Archive

More from Medtech Insight